Central America vs Peru: Proportion of the target population who received the final dose of
Central America
79.0%
in 2024
Peru
97.0%
in 2024
Central America rank
1st
Peru rank
3rd
Proportion of the target population who received the final dose of over time
- Central America
- Peru
How they compare
Peru currently reports 97.0% against 79.0% in Central America, a difference of 18.0%.
That makes Peru's figure about 1.2 times Central America's.
The two have swapped places 4 times across 14 shared years of data; in 2011 it was Peru ahead.
Central America ranks 1st and Peru ranks 3rd of 35 groups.
Across the 2 decades both report, Central America averaged higher in 1 and Peru in 1.
Head to head by decade
| Decade | Central America | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.6% | 40.4% | 21.1% | Central America |
| 2020s | 47.6% | 53.2% | 5.6% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Central America or Peru?
- Peru, at 97.0% against 79.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Central America and Peru?
- 18.0%, with Peru ahead.
- How many years of comparable data are there for Central America and Peru?
- 14 years are reported by both, from 2011 to 2024.
- How do Central America and Peru rank globally for proportion of the target population who received the final dose of?
- Central America ranks 1st and Peru ranks 3rd of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.